The esophagogastric junctional adenocarcinoma an increasing disease

Identifying and defining the esophagogastric junctional adenocarcinoma (EGJA) as an independent disease apart from gastric cancer (GC) and esophagus cancer (EG) it has always been a difficult issue entailing doubts about the appropriate therapeutic approach. In fact, the EGJA is not entirely comparable with GC and EG in terms of epidemiology, risk factors, etiology and pathophysiology.